Fourteen of the 21 animals underwent laser scarring of the trabecular meshwork and were monitored with OCT at approximately two-week intervals to varying endpoints which were based on other unrelated studies.
Table 2 compares the baseline characteristics of the experimental glaucoma sub-group to all animals used for the cannulation study. In this high-pressure experimental glaucoma model, as the cumulative IOP increases, there is a progressive loss of the ONH MRW and circumpapillary RNFL (
Figs. 6A,
6B). The relationship between MRW and circumpapillary RNFL was best described by an exponential rise to maximum fit (
R2 = 0.80, Difference in AICc, compared to a linear fit = 59.4,
Fig. 7C). This relationship was similar to that reported previously for a separate cohort of animals, suggesting a reduction of MRW before thinning of the RNFL.
10
At every imaging session, axial length was measured using ocular biometry. Before the first trabecular meshwork lasering session, the two eyes had similar axial lengths (mean difference = 0.07 mm,
P = 0.47); one animal was identified as an outlier with an axial length difference between the two eyes of 1.2 mm. The change in axial length with cumulative IOP was determined using the difference between the two eyes (
Fig. 7). For this study, early disease was defined as the time point when change in axial length had stabilized. To determine this, the collective data of axial length and cumulative IOP from all subjects was fit with an exponential rise to maximum function. Based on this fit, the half-life was determined to be 256.7 mm Hg · days, suggesting that ∼93% of the maximum axial length change had occurred by 1000 mm Hg · days. At this time point, the axial length of experimental glaucoma eyes had increased by up to 0.82 ± 0.53 mm (
P < 0.01), was similar for both male and female animals (
P = 0.65), and was not statistically different compared to endpoint (mean difference = 0.25 ± 0.39 mm,
P = 0.08). The increase in axial length was mostly attributed to the vitreous chamber (
Table 3), which we believe reflects the stress and strain on the sclera and associated remodeling with elevated IOP.
34,54 Hence, 1000 mm Hg · days was selected as the cutoff for analysis because later time points might not provide a meaningful comparison to baseline pressure challenge data. On average, the 1000 mm Hg · days timepoint was reached at 99.4 ± 28 days, and the imaging session closest to this date was used for determining change in MRW and circumpapillary RNFL thickness from the precannulation baseline. The average IOP after the last laser session up to this point was 25.5 ± 4.4 mm Hg, ranging from 19.6 to 35.3 mm Hg.
At 1000 mm Hg · days, the MRW was reduced by 147.5 ± 87.3 µm (range 51.3 to 355.3 µm) and the circumpapillary RNFL by 26.4 ± 26.4 µm (range 0.5 to 87.5 µm,
Fig. 6) and was not significantly different between male and female animals (
P = 0.77). In the stepwise regression, the reduction in MRW was related to the change in AL (Loss of MRW = −31.7 + 236.4 × change in AL,
R2 = 0.80,
P < 0.01,
Supplementary Table S5). For the loss of RNFL, in addition to the change in AL, baseline CCT was also identified as a significant predictor (Loss of RNFL = −163.8 + 63.8 × Change in AL + 0.30 × CCT,
R2 = 0.80,
P < 0.01,
Supplementary Table S6).
Figure 7 illustrates the change in axial length with cumulative IOP, and the association between the extent of axial elongation at 1000 mm Hg · days and the loss of MRW and RNFL (for illustration, CCT is not included).
A separate stepwise linear regression was performed to determine if the loss of MRW and RNFL at 1000 mm Hg · days were correlated with metrics from the pressure challenge experiments. This analysis identified the MRW return at 10 mm Hg as the only predictor variable for loss of both MRW and RNFL (Loss of MRW = −83.8 + 14.2 MRW return,
R2 = 0.61,
P < 0.01, Loss of RNFL = −50.3 + 4.7 MRW return,
R2 = 0.75,
P < 0.01;
Figure 8,
Supplementary Tables S7,
S8).